Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific.

HIV medicine - 1 Mar 2021

Ross J, Jiamsakul A, Kumarasamy N, Azwa I, Merati T P, Do C D, Lee M P, Ly P S, Yunihastuti E, Nguyen K V, Ditangco R, Ng O T, Choi J Y, Oka S, Sohn A H, Law M

Abstract excerpt

OBJECTIVES: To assess second-line antiretroviral therapy (ART) virological failure and HIV drug resistance-associated mutations (RAMs), in support of third-line regimen planning in Asia. METHODS: Adults > 18 years of age on second-line ART for ≥ 6 months were eligible. Cross-sectional data on HIV viral load (VL) and genotypic resistance testing were collected or testing was conducted between July 2015 and May...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Mutation

Share to Treatment Failure

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 33151020
DOI: 10.1111/hiv.13006
PMCID: PMC7886962

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific.PMID 33151020Read ↗

HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia.Semantic proximity Read ↗

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaSemantic proximity Read ↗

High prevalence of PI resistance in patients failing second-line ART in Vietnam.Semantic proximity Read ↗

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.Semantic proximity Read ↗

High Prevalence of Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy and Predictors of Virological Response 24 Weeks After Switch to Second-Line Therapy in São Paulo State, Brazil.Semantic proximity Read ↗

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.Semantic proximity Read ↗

HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya.Semantic proximity Read ↗

Emergence of HIV-1 drug resistance mutations among children and adolescents undergoing prolonged antiretroviral therapy in Guangxi.Semantic proximity Read ↗

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in ChinaSemantic proximity Read ↗

HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020.Semantic proximity Read ↗

HIV drug resistance among patients experiencing antiretroviral therapy failure in Russia, 2019-2021.Semantic proximity Read ↗

Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.